Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II study. [electronic resource]
Producer: 20061108Description: 389-94 p. digitalISSN:- 0939-5555
- Adult
- Aged
- Aged, 80 and over
- Bone Marrow -- pathology
- Chromosome Banding
- Chromosome Deletion
- Chromosomes, Human, Pair 5 -- genetics
- Drug Eruptions -- etiology
- Drug Therapy, Combination
- Erythropoiesis -- drug effects
- Follow-Up Studies
- Hemoglobins -- analysis
- Humans
- In Situ Hybridization, Fluorescence
- Middle Aged
- Myelodysplastic Syndromes -- blood
- Quality of Life
- Treatment Outcome
- Tretinoin -- administration & dosage
- alpha-Tocopherol -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.